{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:06:54Z","timestamp":1767834414791,"version":"3.49.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,6]],"date-time":"2014-07-06T00:00:00Z","timestamp":1404604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.bpobgyn.2014.05.003","type":"journal-article","created":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T14:51:56Z","timestamp":1401979916000},"page":"795-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Progestin-only contraception: Injectables and implants"],"prefix":"10.1016","volume":"28","author":[{"given":"Roy","family":"Jacobstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chelsea B.","family":"Polis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.05.003_bib1","series-title":"Home-based administration of depo-subQ provera 104\u2122 in the Uniject\u2122 injection system: a literature review","author":"Keith","year":"2011"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib2","series-title":"Contraceptive technology","author":"Hatcher","year":"2011"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib3","series-title":"Jadelle\u00ae Levonorgestrel rod implants: a summary of scientific data and lessons learned from programmatic experience","author":"Sivin","year":"2002"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.02.140","article-title":"Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials","volume":"91","author":"Darney","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.contraception.2010.04.007","article-title":"Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial","volume":"82","author":"Mansour","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2009.10.013","article-title":"Sino-implant (II)\u2013a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials","volume":"81","author":"Steiner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib7","series-title":"Jadelle training manual for family planning","author":"Bayer Schering Pharma","year":"2008"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib8","series-title":"Contraceptive commodities for women\u2019s health","author":"United Nations Commission on life-saving commodities for women and children","year":"2012"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bpobgyn.2010.02.002","article-title":"Why do women experience untimed pregnancies? A review of contraceptive failure rates","volume":"24","author":"Black","year":"2010","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0010-7824(83)80002-X","article-title":"Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report","volume":"28","year":"1983","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib13","series-title":"IMPLANON NXT\u2122: reference guide","author":"Sharp","year":"2013"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib14","series-title":"Family planning: a global handbook for providers, 2011 update","author":"Johns Hopkins Bloomberg School of Public Health\/Center for Communication Programs and World Health Organization","year":"2011"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib15","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0002-9378(96)70658-0","article-title":"The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization","volume":"174","author":"Peterson","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib17","first-page":"CD008452","article-title":"Hormonal contraceptives for contraception in overweight or obese women","volume":"4","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2217\/whe.13.41","article-title":"Obesity and hormonal contraceptive efficacy","volume":"9","author":"Robinson","year":"2013","journal-title":"Women Health"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-7824(96)00276-4","article-title":"Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants","volume":"55","author":"Sivin","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib21","series-title":"Selected practice recommendations for contraceptive use","author":"World Health Organization","year":"2004"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib22","series-title":"Medical eligibility criteria for contraceptive use","author":"Department of Reproductive Health, World Health Organization","year":"2009"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib23","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0140-6736(99)01578-0","article-title":"Checklist for ruling out pregnancy among family-planning clients in primary care","volume":"354","author":"Stanback","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib24","first-page":"1","article-title":"US selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition","volume":"62","author":"Curtis","year":"2013","journal-title":"MMWR"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib25","series-title":"Selected practice recommendations for contraceptive use, 2008 update","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1728-4465.2005.00073.x","article-title":"Ruling out pregnancy among family planning clients: the impact of a checklist in three countries","volume":"36","author":"Stanback","year":"2005","journal-title":"Stud Fam Plann"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.05.003_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.contraception.2013.11.008","article-title":"Preference for Sayana Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial","volume":"89","author":"Polis","year":"2014","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.05.003_bib28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.contraception.2014.01.022","article-title":"Observational study of the acceptability of Sayana Press among intramuscular DMPA users in Uganda and Senegal","volume":"89","author":"Burke","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.contraception.2013.07.002","article-title":"Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm","volume":"89","author":"Halpern","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.contraception.2008.01.017","article-title":"Injectable contraception: what should the longest interval be for reinjections?","volume":"77","author":"Steiner","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(80)92765-8","article-title":"Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine Devices in Northern Thailand","volume":"315","author":"Pardthaisong","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib32","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0010-7824(74)90073-0","article-title":"The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function and the return of fertility following its discontinuation: a review","volume":"10","author":"Schwallie","year":"1974","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0010-7824(84)90018-0","article-title":"Return of ovulation and fertility in women using norethisterone oenanthate","volume":"29","author":"Fotherby","year":"1984","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.contraception.2004.01.011","article-title":"Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.9745\/GHSP-D-12-00003","article-title":"Contraceptive implants: providing better choice to meet growing family planning demand","volume":"1","author":"Jacobstein","year":"2013","journal-title":"Global Health Sci Pract"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.contraception.2012.10.012","article-title":"Women's preferences for contraceptive counseling and decision making","volume":"88","author":"Dehlendorf","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.contraception.2008.10.012","article-title":"Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literature","volume":"79","author":"Bachmann","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0010-7824(88)90038-8","article-title":"Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception","volume":"38","author":"Belsey","year":"1988","journal-title":"Contraception"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2014.05.003_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J ContraceptReprod Health Care"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib41","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib42","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.contraception.2006.12.009","article-title":"Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg\/0.65 mL","volume":"75","author":"Westhoff","year":"2007","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.contraception.2010.08.001","article-title":"The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users","volume":"83","author":"Mansour","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-7824(97)00140-6","article-title":"Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation","volume":"56","author":"Paul","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib45","first-page":"CD008815","article-title":"Progestin-only contraceptives: effects on weight","volume":"7","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.contraception.2009.07.007","article-title":"Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception","volume":"81","author":"Beksinska","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib47","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0010-7824(88)90051-0","article-title":"Acceptability of injectable contraceptives in Assiut, Egypt","volume":"38","author":"Salem","year":"1988","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib48","series-title":"Depo-subQ provera 104\u2122 medroxyprogesterone acetate injectable suspension 104 mg\/0.65 mL: physician onformation","author":"Pfizer Inc","year":"2009"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib49","series-title":"DEPO-PROVERA CI (medroxyprogesterone acetate) injectable suspension, for intramuscular use: physician information","author":"Inc","year":"2012"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib50","first-page":"CD009849","article-title":"Steroidal contraceptives and bone fractures in women: evidence from observational studies","volume":"8","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib51","first-page":"CD006033","article-title":"Steroidal contraceptives: effect on bone fractures in women","author":"Lopez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/AOG.0b013e318283d1a1","article-title":"Use of depot medroxyprogesterone acetate contraception and incidence of bone fracture","volume":"121","author":"Lanza","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib53","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.contraception.2006.01.002","article-title":"WHO statement on hormonal contraception and bone health","volume":"73","author":"d'Arcangues","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib54","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e318188d1ec","article-title":"ACOG Committee Opinion No. 415: depot medroxyprogesterone acetate and bone effects","volume":"112","author":"ACOG","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2011.01.009","article-title":"Removing the black box warning for depot medroxyprogesterone acetate","volume":"84","author":"Kaunitz","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib56","doi-asserted-by":"crossref","first-page":"R263","DOI":"10.1677\/ERC-10-0076","article-title":"Hormonal contraception and risk of endometrial cancer: a systematic review","volume":"17","author":"Mueck","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib57","first-page":"191","article-title":"The WHO collaborative study of neoplasia and steroid contraceptives","volume":"49","author":"Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib58","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1158\/0008-5472.CAN-11-4064","article-title":"Effect of depo-medroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age","volume":"72","author":"Li","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib59","doi-asserted-by":"crossref","first-page":"e1001182","DOI":"10.1371\/journal.pmed.1001182","article-title":"Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: case-control study","volume":"9","author":"Urban","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib60","first-page":"299","article-title":"The WHO collaborative study of neoplasia and steroid contraceptives","volume":"45","author":"Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer","year":"1992","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib61","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1093\/humrep\/13.11.3057","article-title":"A\u00a02-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK","volume":"13","author":"Mascarenhas","year":"1998","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib62","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1002\/ijc.22970","article-title":"Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women","volume":"121","author":"Sweeney","year":"2007","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.05.003_bib63","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.contraception.2014.01.009","article-title":"Provider acceptability of Sayana\u00ae Press: results from community health workers and clinic-based providers in Uganda and Senegal","volume":"89","author":"Burke","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0010-7824(01)00281-5","article-title":"Users' perspectives on implantable contraceptives for women","volume":"65","author":"Ortayli","year":"2002","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib65","series-title":"Causes and consequences of contraceptive discontinuation: evidence from 60 demographic and health surveys","author":"Ali","year":"2012"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib66","first-page":"CD001326","article-title":"Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy","author":"Power","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1363\/3913313","article-title":"Reducing unmet need by supporting women with met need","volume":"39","author":"Jain","year":"2013","journal-title":"Int Perspect Sex Reprod Health"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib68","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/AOG.0b013e3182723b7d","article-title":"Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices","volume":"120","author":"Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib69","series-title":"From evidence to policy: optimizing the health workforce for effective family planning services","author":"World Health Organization. WHO policy brief","year":"2012"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.05.003_bib70","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.contraception.2014.01.005","article-title":"Operational assessments of Sayana\u00ae Press provision in Senegal and Uganda","volume":"89","author":"Cover","year":"2014","journal-title":"Contraception"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.05.003_bib71","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.contraception.2013.12.010","article-title":"Perceptions of home and self-injection of Sayana\u00ae Press in Ethiopia: a qualitative study","volume":"89","author":"Keith","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.9745\/GHSP-D-13-00116","article-title":"Scaling up delivery of contraceptive implants in sub-Saharan Africa: operational experiences of Marie Stopes International","volume":"2","author":"Duvall","year":"2014","journal-title":"Glob Health Sci Pract"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2014.05.003_bib73","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijgo.2013.07.003","article-title":"Addressing unmet need for long-acting family planning in Ethiopia: uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users","volume":"123","author":"Asnake","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib74","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-94-007-6722-5_14","article-title":"Global introduction of a low-cost contraceptive implant","volume":"33","author":"Rademacher","year":"2014","journal-title":"Crit Issues Reprod Health"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib75","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2010.06.016","article-title":"The promise of affordable implants: is cost recovery possible in Kenya?","volume":"83","author":"Tumlinson","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib76","article-title":"London summit puts family planning back on the agenda, offers new lease on life for millions of women and girls","volume":"15","author":"Cohen","year":"2012","journal-title":"Guttmacher Policy Review"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib77","series-title":"Innovative partnership reduces cost of Bayer's long-acting reversible contraceptive implant by more than 50 percent (press release)","author":"Bill and Melinda Gates Foundation","year":"2013"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib78","series-title":"MSD and partners announce agreement to increase access to innovative contraceptive implants Implanon\u00ae and Implanon NXT\u00ae in the poorest countries (Press Release)","author":"MSD","year":"2013"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib79","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.contraception.2008.08.003","article-title":"Cost effectiveness of contraceptives in the United States","volume":"79","author":"Trussell","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.bpobgyn.2014.05.003_bib80","doi-asserted-by":"crossref","first-page":"115e1","DOI":"10.1016\/j.ajog.2010.04.017","article-title":"The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception","volume":"203","author":"Secura","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib81","series-title":"World contraceptive use 2011","author":"United Nations Department of Economic and Social Affairs Population Division","year":"2011"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib82","series-title":"STATcompiler. Calverton, MD","author":"The DHS Program","year":"2012"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2014.05.003_bib83","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.ijgo.2013.02.005","article-title":"Meeting the need for modern contraception: effective solutions to a pressing global challenge","volume":"121","author":"Jacobstein","year":"2013","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib84","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.contraception.2010.08.021","article-title":"Dedicated providers of long-acting reversible contraception: new approach in Zambia","volume":"83","author":"Neukom","year":"2011","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib85","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.12.014","article-title":"An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women","volume":"80","author":"Rodriguez","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib86","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.contraception.2009.05.124","article-title":"Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study","volume":"80","author":"Brito","year":"2009","journal-title":"Contraception"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib87","series-title":"Long-acting and reversible contraception: the effective and appropriate use of long-acting and reversible contraception","year":"2005"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib88","series-title":"Canadian contraception consensus, 143 \u2013 Part 2 of 3","author":"The Society of Gynaecologists and Obstetricians of Canada","year":"2004"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib89","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2307\/2673801","article-title":"Contraception use, intention to use and unmet need during the extended postpartum period","volume":"27","author":"Ross","year":"2001","journal-title":"Int Fam Plan Perspect"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib90","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1473-3099(13)70155-5","article-title":"Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence","volume":"13","author":"Polis","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib91","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/QAD.0b013e32835ad539","article-title":"Hormonal contraceptive use and female-to-male HIV transmission: a systematic review of the epidemiologic evidence","volume":"27","author":"Polis","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":"Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib93","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0b013e32835bb672","article-title":"Effect of hormonal contraceptive methods on HIV disease progression: a systematic review","volume":"27","author":"Phillips","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib94","series-title":"Hormonal contraception and HIV: technical statement","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib95","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1097\/QAD.0000000000000036","article-title":"The effect of hormonal contraception on HIV acquisition: analytic approaches and challenges in observational data","volume":"27","author":"Polis","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib96","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/17425255.2013.772579","article-title":"Drug interactions between antiretrovirals and hormonal contraceptives","volume":"9","author":"Tseng","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib97","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0140-6736(12)60478-4","article-title":"Maternal deaths averted by contraceptive use: an analysis of 172 countries","volume":"380","author":"Ahmed","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2014.05.003_bib98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAD.0b013e32835a5a52","article-title":"Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk","volume":"27","author":"Butler","year":"2013","journal-title":"AIDS"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T12:24:01Z","timestamp":1538569441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1521693414001035"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.05.003","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progestin-only contraception: Injectables and implants","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}